Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

ecancermedicalscience

Please Note: The journal will be closed for new submissions from Mon Jun 15th 2026 for approximately 2 months to enable us to catch up with a backlog due to record numbers in recent months.

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Enrique Soto Pérez de Celis MD, PhD, FASCO

ISSN: 1754-6605

NB:

  • The journal does not accept case reports
  • From 6 April 2026 APCs will apply to manuscripts submitted from countries classified as upper-middle-income or high-income.
  • Manuscripts may be declined after 60 days if suitable reviewers cannot be secured, to minimise delays and allow authors to submit their work elsewhere.
Articles
Editorials
Special issues
Author interviews
706-why-a-d2-gastrectomy-plus-adjuvant-chemotherapy-is-insufficient-in-locally-advanced-gastric-cancer
Sebastián Z Solé, Francisco E Larsen, Claudio V Solé
705-central-nervous-system-metastasis-secondary-to-colorectal-cancer-a-retrospective-cohort-study-of-20-cases
Sebastián Mondaca, Valentina Hornig, Pablo Munoz-Schuffenegger, Francisco Acevedo, Marcelo Garrido, Bruno Nervi
704-cancer-of-the-gallbladder-chilean-statistics
Luis Villanueva Olivares
699-replacing-5-fluorouracil-by-capecitabine-in-localised-squamous-cell-carcinoma-of-the-anal-canal-systematic-review-and-meta-analysis
Karla T Souza, Allan AL Pereira, Raphael L Araujo, Suilane Coelho Ribeiro Oliveira, Paulo M Hoff, Rachel P Riechelmann
691-cancer-immunotherapy-from-the-lab-to-clinical-applications-potential-impact-on-cancer-centres-organisation
Linda Cairns, Sandrine Aspeslagh, Andrea Anichini, Jon Amund Kyte, Christian Blank, Paolo Ascierto, Nicolle Rekers, Per Thor Straten, Ahmad Awada
677-veror-radiotherapy-for-low-burden-cancer-789-patients-with-957-lesions
R Orecchia, A Surgo, M Muto, A Ferrari, G Piperno, MA Gerardi, S Comi, C Garibaldi, D Ciardo, A Bazani, F Golino, F Pansini, C Fodor, P Romanelli, D Maestri, V Scroffi, S Mazza, BA Jereczek-Fossa
670-maps-and-atlases-of-cancer-mortality-a-review-of-a-useful-tool-to-trigger-new-questions
Alberto d'Onofrio, Chiara Mazzetta, Chris Robertson, Michel Smans, Peter Boyle, Mathieu Boniol
669-highlights-from-the-2016-win-symposium-27-29-june-2016-paris-personalised-therapy-beyond-next-generation-sequencing
Richard Schilsky, Will Davies
646-squamous-cell-carcinoma-of-the-rectum-a-consequence-of-immunosuppression-resulting-from-inhibiting-tumour-necrosis-factor-tnf
Alexandra Silverton, Roy A Raad, Leah Katz, Andrea Downey, Franco M Muggia
629-pet-ct-with-fluorodeoxyglucose-during-neoadjuvant-chemoradiotherapy-in-locally-advanced-rectal-cancer
Laura L Travaini, Maria G Zampino, Marzia Colandrea, Mahila E Ferrari, Laura Gilardi, Maria C Leonardi, Luigi Santoro, Roberto Orecchia, Chiara M Grana

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation